C07C 307/02
Monoamides of sulfuric acids or esters thereof
Official title: Monoamides of sulfuric acids or esters thereof, e.g. sulfamic acids
C07C307/02 (Monoamides of sulfuric acids or esters thereof) appears on 152 US grants and 148 published applications in this corpus.
Search patents in C07C- Granted patents
- 152
- Published applications
- 148
- Assignees
- 134
- Inventors
- 534
- Latest grant
- 10 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 1 | 0 |
| 1978 | 3 | 0 |
| 1979 | 0 | 0 |
| 1980 | 2 | 0 |
| 1981 | 3 | 0 |
| 1982 | 2 | 0 |
| 1983 | 2 | 0 |
| 1984 | 1 | 0 |
| 1985 | 2 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 4 | 0 |
| 1992 | 1 | 0 |
| 1993 | 5 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 3 | 0 |
| 1997 | 4 | 0 |
| 1998 | 4 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 3 | 1 |
| 2002 | 6 | 4 |
| 2003 | 1 | 4 |
| 2004 | 5 | 7 |
| 2005 | 0 | 11 |
| 2006 | 0 | 4 |
| 2007 | 5 | 3 |
| 2008 | 6 | 2 |
| 2009 | 4 | 6 |
| 2010 | 3 | 8 |
| 2011 | 2 | 7 |
| 2012 | 5 | 4 |
| 2013 | 7 | 3 |
| 2014 | 6 | 9 |
| 2015 | 6 | 2 |
| 2016 | 4 | 6 |
| 2017 | 5 | 7 |
| 2018 | 2 | 3 |
| 2019 | 5 | 5 |
| 2020 | 5 | 6 |
| 2021 | 5 | 9 |
| 2022 | 4 | 4 |
| 2023 | 3 | 11 |
| 2024 | 5 | 11 |
| 2025 | 4 | 7 |
| 2026 | 1 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- FABP4/5 inhibitors, methods of use and methods of making10 Mar 2026US 12,570,603 B2Celloram Inc.
- Modulators of liver receptor homologue 1 (LRH-1) and uses16 Sep 2025US 12,415,770 B2Emory University Office of Technology Transfer
- Isofagomine salts, methods of use and formulations29 Apr 2025US 12,286,400 B2Takeda Pharmaceutical Company Limited
- Affinity illudofulvene conjugates8 Apr 2025US 12,269,793 B2AF Chemicals, LLC
- Gamma-hydroxybutyrate delivering compounds and processes for making and using them18 Mar 2025US 12,251,445 B2Zevra Therapeutics, Inc.
- Fabp4/5 inhibitors, methods of use and methods of making14 May 2026US 2026/0132106 A1Celloram Inc.
- Crystalline salt forms of n-((1-(2-(tert-butylamino)-2-oxoethyl)piperidin-4-yl) methyl)-3-chloro-5-fluorobenzamide and methods of use thereof2 Apr 2026US 2026/0092037 A1Praxis Precision Medicines, Inc.
- Modulators of liver receptor homologue 1 (lrh-1) and uses26 Feb 2026US 2026/0055046 A1Emory University
- Compounds, compositions, and methods for reducing production of trimethylamine1 Jan 2026US 2026/0001833 A1The Cleveland Clinic Foundation
- Gamma-hydroxybutyrate delivering compounds and processes for making and using them4 Dec 2025US 2025/0367299 A1Zevra Therapeutics, Inc.
Most cited
By later US patents
- Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs103US 5,366,997 AThe United States of America, as represented by the Secretary, Department of Health and Human Services · 1994
- Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof75US 5,039,705 AThe United States of America as represented by the Department of Health and Human Services · 1991
- Non-steroidal sulfatase inhibitor compounds and their method of use71US 5,567,831 ADuguesne University of the Holy Ghost · 1996
- Pharmaceutical tramadol salts69US 6,723,343 B2Gruenenthal GmbH · 2004
- Fluorinated ionic sulfonylimides and sulfonylmethylides, process of preparing same and use thereof as photoinitiators49US 6,008,265 ACentre National De La Recherche Scientifique · 1999